SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-004643
Filing Date
2024-02-02
Accepted
2024-02-01 21:04:39
Documents
16
Period of Report
2024-01-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40077
2 ex99-1.htm EX-99.1 14423
3 ex99-1_001.jpg GRAPHIC 5541
  Complete submission text file 0001493152-24-004643.txt   240381

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fblg-20240131.xsd EX-101.SCH 3033
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fblg-20240131_lab.xml EX-101.LAB 34240
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT fblg-20240131_pre.xml EX-101.PRE 22371
17 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3738
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics Inc. (Filer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41934 | Film No.: 24588589
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)